1. Home
  2. RGEN vs DRS Comparison

RGEN vs DRS Comparison

Compare RGEN & DRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$177.23

Market Cap

10.0B

Sector

Health Care

ML Signal

N/A

Logo Leonardo DRS Inc.

DRS

Leonardo DRS Inc.

N/A

Current Price

$36.76

Market Cap

9.8B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
RGEN
DRS
Founded
1981
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.0B
9.8B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
RGEN
DRS
Price
$177.23
$36.76
Analyst Decision
Buy
Strong Buy
Analyst Count
22
11
Target Price
★ $189.70
$53.82
AVG Volume (30 Days)
★ 880.1K
724.0K
Earning Date
10-27-2026
10-29-2026
Dividend Yield
N/A
★ 0.98%
EPS Growth
★ 286.96
28.75
EPS
0.24
★ 0.55
Revenue
$141,236,000.00
★ $3,648,000,000.00
Revenue This Year
$12.04
$8.27
Revenue Next Year
$17.80
$6.96
P/E Ratio
$805.46
★ $66.53
Revenue Growth
★ 35.10
12.80
52 Week Low
$100.99
$32.43
52 Week High
$198.87
$50.59

Technical Indicators

Market Signals
Indicator
RGEN
DRS
Relative Strength Index (RSI) 63.35 37.30
Support Level $159.22 $35.12
Resistance Level N/A $38.25
Average True Range (ATR) 6.58 0.88
MACD 0.98 0.23
Stochastic Oscillator 75.63 47.61

Price Performance

Historical Comparison
RGEN
DRS

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

About DRS Leonardo DRS Inc.

Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. It is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.

Share on Social Networks: